RNA-binding protein dysfunction in neurodegeneration

Essays Biochem. 2021 Dec 22;65(7):975-986. doi: 10.1042/EBC20210024.

Abstract

Protein homeostasis (proteostasis) is a prerequisite for cellular viability and plasticity. In particular, post-mitotic cells such as neurons rely on a tightly regulated safeguard system that allows for regulated protein expression. Previous investigations have identified RNA-binding proteins (RBPs) as crucial regulators of protein expression in nerve cells. However, during neurodegeneration, their ability to control the proteome is progressively disrupted. In this review, we examine the malfunction of key RBPs such as TAR DNA-binding protein 43 (TDP-43), Fused in Sarcoma (FUS), Staufen, Pumilio and fragile-X mental retardation protein (FMRP). Therefore, we focus on two key aspects of RBP dysfunctions in neurodegeneration: protein aggregation and dysregulation of their target RNAs. Moreover, we discuss how the chaperone system responds to changes in the RBP-controlled transcriptome. Based on recent findings, we propose a two-hit model in which both, harmful RBP deposits and target mRNA mistranslation contribute to neurodegeneration observed in RBPathologies.

Keywords: ALS; Aggregation; Chaperones; FTD; FXTAS; stress granules.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Humans
  • RNA / genetics
  • RNA, Messenger / genetics
  • RNA-Binding Protein FUS* / genetics
  • RNA-Binding Protein FUS* / metabolism

Substances

  • RNA, Messenger
  • RNA-Binding Protein FUS
  • RNA